In vivo bioimaging using photogenic rats: Fate of injected bone marrow-derived mesenchymal stromal cells

Journal of Autoimmunity

Volumn 30, Issue 3, 2008, Pages 163-171

  Hara, Mayumi ^a   Murakami, Takashi ^a   Kobayashi, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemokine receptors; Luciferase; Luminescent imaging; Transgenic rat

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; ENDOGLIN; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; LUCIFERASE; PHOTOPROTEIN; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN;

BONE MARROW; CANCER CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CHEMOTAXIS; CULTURE MEDIUM; HEMATOPOIETIC STEM CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MESENCHYMAL STEM CELL; METASTASIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROMA CELL; TISSUE REGENERATION; TISSUE REPAIR; WOUND HEALING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL MOVEMENT; CHEMOTAXIS; DIAGNOSTIC IMAGING; LUMINESCENT PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; REGENERATIVE MEDICINE; STROMAL CELLS;

EID: 39149119243     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.12.007     Document Type: Review

References (78)

1. Murakami T., and Kobayashi E. Color-engineered rats and luminescent LacZ imaging: a new platform to visualize biological processes. J Biomed Opt 10 41204 (2005) 1-10
2. Beck J.A., Lloyd S., Hafezparast M., Lennon-Pierce M., Eppig J.T., Festing M.F., et al. Genealogies of mouse inbred strains. Nat Genet 24 (2000) 23-25
3. Hallbergson A.F., Gnatenco C., and Peterson D.A. Neurogenesis and brain injury: managing a renewable resource for repair. J Clin Invest 112 (2003) 1128-1133
4. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
5. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96 (1999) 10711-10716
6. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
7. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (2000) 1775-1779
8. Mezey E., Chandross K.J., Harta G., Maki R.A., and McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 (2000) 1779-1782
9. Woodbury D., Schwarz E.J., Prockop D.J., and Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61 (2000) 364-370
10. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 100 (2003) 11917-11923
11. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 (2004) 9-20
12. Giordano A., Galderisi U., and Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211 (2007) 27-35
13. Contag C.H., and Bachmann M.H. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4 (2002) 235-260
14. Lippincott-Schwartz J., and Patterson G.H. Development and use of fluorescent protein markers in living cells. Science 300 (2003) 87-91
15. Hoffman R.M. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 10 (2005) 796-806
16. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
17. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
18. Beyer Nardi N., and da Silva Meirelles L. Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174 (2006) 249-282
19. Sethe S., Scutt A., and Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 5 (2006) 91-116
20. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2 (1974) 83-92
21. Mendelow B., Grobicki D., de la Hunt M., Katz J., and Metz J. Characterization of bone marrow stromal cells in suspension and monolayer cultures. Br J Haematol 46 (1980) 15-22
22. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., and Owen M.E. Evidence for an inverse relationship between the differentiate on of adipocyte and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102 (1992) 314-351
23. Rickard D., Sullivan T., Shenker B., Leboy P.S., and Kazhdan I. Induction of rapid osteoblast differentiation in rat marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161 (1994) 218-228
24. Herbertson A., and Aubin J. Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures. Bone 21 (1997) 491-500
25. Phinney D.G., Kopen G., Isaacson R.L., and Prockop D.J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72 (1999) 570-585
26. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28 (2000) 875-884
27. Colter D.C., Class R., DiGirolamo C.M., and Prockop D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U.S.A 97 (2000) 3213-3218
28. Javazon E.H., Colter D.C., Schwarz E.J., and Prockop D.J. Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 19 (2001) 219-225
29. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., and Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 (2004) 1662-1668
30. Digirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., and Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107 (1999) 275-281
31. Satake K., Lou J., and Lenke L.G. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 29 (2004) 1971-1979
32. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104 (2004) 2643-2645
33. Ji J.F., He B.P., Dheen S.T., and Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22 (2004) 415-427
34. Le Blanc K., and Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol 18 (2006) 586-591
35. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., and Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62 (2002) 3603-3608
36. Studeny M., Marini F.C., Dembinski J.L., Zompetta C., Cabreira-Hansen M., Bekele B.N., et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96 (2004) 1593-1603
37. Wakitani S., Saito T., and Caplan A. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18 (1995) 1417-1426
38. Ferrari G., Cuaella G., Angelia D., Coletta M., Paolucci E., Stornaiuolo A., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
39. Dezawa M., Ishikawa M., Itokazu Y., Yoshihara T., Hoshino M., Takeda S., et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309 (2005) 314-317
40. Mahmood A., Lu D., Lu M., and Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53 (2003) 697-702
41. Fukuda K., and Fujita J. Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int 68 (2005) 1940-1943
42. Sampaoleai M., Torrente Y., Innocenzi A., Tonlorenzi R., D'Antona G., Pallegrino M.A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
43. Sampaoleai M., Blot S., D'Antona G., Granger N., Tonlorenzi R., Innocenzi A., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444 (2006) 574-579
44. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65 (2005) 3307-3318
45. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
46. Hasebe T., Sasaki S., Imoto S., and Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol 4 (2001) 325-337
47. Kuniyasu H., Abbruzzese J.L., Cleary K.R., and Fidler I.J. Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19 (2001) 681-685
48. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
49. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
50. Kunkel E.J., and Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 16 (2002) 1-4
51. Murakami T., Cardones A.R., and Hwang S.T. Chemokine receptor and melanoma metastasis. J Dermatol Sci 36 (2004) 71-78
52. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
53. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
54. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., and McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62 (2002) 1832-1837
55. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., and Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 (2001) 2396-2402
56. Menon L.G., Picinich S., Koneru R., Gao H., Lin Y.S., Koneru M., et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25 (2007) 520-528
57. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203 (2006) 2201-2213
58. De Clercq E. The bicyclam AMD3100 story. Nat Rev Drug Discov 2 (2003) 581-587
59. Cardones A.R., Murakami T., and Hwang S.T. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta1 integrin. Cancer Res 63 (2003) 6751-6757
60. Takeda S., Takahashi M., Sado Y., Takeuchi K., Hakamata Y., Shimizu H., et al. Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo. Nephron Exp Nephrol 96 (2004) 119-126
61. Fujishiro J., Takeda S., Takeno Y., Takeuchi K., Ogata Y., Takahashi M., et al. Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression. Nephrol Dial Transplant 20 (2005) 1385-1391
62. Yoshino H., Hashizume K., and Kobayashi E. Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume. Gene Ther 13 (2006) 1696-1702
63. Haga J., Wakabayashi G., Shimazu M., Tanabe M., Takahara T., Azuma T., et al. In vivo visualization and portally repeated transplantation of bone marrow cells in rats with liver damage. Stem Cells Dev 16 (2007) 319-328
64. Bianco P., and Gehron Robey P. Marrow stromal stem cells. J Clin Invest 105 (2000) 1663-1668
65. Hakamata Y., Murakami T., and Kobayashi E. Firefly rats as an organ/cellular source for long-term in vivo bioluminescent imaging. Transplantation 81 (2006) 1179-1184
66. Inoue H., Ohsawa I., Murakami T., Kimura A., Hakamata Y., Sato Y., et al. Development of new inbred transgenic strains of rats with LacZ and GFP. Biochem Biophys Res Commum 329 (2005) 289-296
67. Osawa I., Murakami T., Uemoto S., and Kobayashi E. In vivo luminescent imaging of cyclosporine A-mediated cancer progression in rats. Transplantation 81 (2006) 1558-1567
68. Abraham N., Li M., Vanella L., Peterson S., Ikehara S., and Asprinio D. Bone marrow stem cell transplant into intra-bone cavity prevent Type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmunity 30 (2008) 128-135
69. Boren E.J., Cheema G.S., Naguwa S.M., Ansari A.A., and Gershwin M.E. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmunity 30 1-2 (2007) 90-98
70. Burt R., Craig R., Cohen B., Suffit R., and Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: What have we learned?. J Autoimmunity 30 (2008) 116-120
71. Deane S., Meyers F., and Gershwin M. On reversing the persistence of memory: Hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmunity 2008 30 (2007) 180-196
72. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmunity 30 (2008) 105-107
73. Ikehara S. Innovative BMT method for intractable diseases. Immunol Res 38 1-3 (2007) 251-260
74. Marmont A. Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmunity 30 (2008) 145-150
75. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmunity 30 (2008) 121-127
76. Ratajczak M.Z., Zuba-Surma E.K., Wysoczynski M., Wan W., Ratajczak J., Wojakowski W., et al. Hunt for pluripotent stem cell - regenerative medicine search for almighty cell. J Autoimmunity 30 (2008) 151-162
77. Rezvani A., and Storb R. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmunity 30 (2008) 172-179
78. Sonoda Y. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. J Autoimmunity 30 (2008) 136-144